Prevail Global Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1205 participants.

Also called NCT06535854

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,205 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06535854
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Germany, Hong Kong SAR China, Ireland, Japan, Singapore, South Korea, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06535854. Randomized; single masking; primary purpose treatment. Start 2025-02-24 (actual); primary completion 2027-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevail Global Study
Intervention (Device)
Prevail DCB
Intervention (Device)
Agent DCB
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct06535854
Content hash
275d99a926329bc93234183af09fd6166d824500bdb7ce7d05a7810735ebbdb1